Which has preferable earnings & valuation, CCFS or CYBG?

VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Charter Court Financial Services Grp, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Charter Court Financial Services Grp £221.10M 0.00 N/A £46.30 N/A VanEck Bionic Engineering UCITS ETF A Acc £1.24B 0.15 N/A -£7.10 N/A

Is CCFS or CYBG more profitable?

Company Net Margins Return on Equity Return on Assets Charter Court Financial Services Grp N/A N/A N/A VanEck Bionic Engineering UCITS ETF A Acc N/A N/A N/A

Which has higher earnings and valuation, CYBG or CIHL?

VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Caribbean Investment, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio VanEck Bionic Engineering UCITS ETF A Acc £1.24B 0.15 N/A -£7.10 N/A Caribbean Investment £29.20M 0.00 N/A £8.60 N/A

Is CYBG or CIHL more profitable?

Company Net Margins Return on Equity Return on Assets VanEck Bionic Engineering UCITS ETF A Acc N/A N/A N/A Caribbean Investment N/A N/A N/A

Do analysts recommend CYBG or POLR?

Polar Capital has a consensus price target of GBX 848.33, indicating a potential downside of 2.71%. Given Polar Capital's stronger consensus rating and higher probable upside, analysts plainly believe Polar Capital is more favorable than VanEck Bionic Engineering UCITS ETF A Acc. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VanEck Bionic Engineering UCITS ETF A Acc 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Polar Capital 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has better valuation and earnings, BGSC or CYBG?

VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than BMO Global Smaller Companies, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BMO Global Smaller Companies £303.85M 0.00 N/A £50.70 N/A VanEck Bionic Engineering UCITS ETF A Acc £1.24B 0.15 N/A -£7.10 N/A

Is BGSC or CYBG more profitable?

Company Net Margins Return on Equity Return on Assets BMO Global Smaller Companies N/A N/A N/A VanEck Bionic Engineering UCITS ETF A Acc N/A N/A N/A

VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Competitors

GBX 13.31 +0.03 (+0.20%)

As of 05:34 AM Eastern

Compare

CYBG vs. CCFS, CIHL, IL0A, POLR, and BGSC

Should you buy VanEck Bionic Engineering UCITS ETF A Acc stock or one of its competitors? MarketBeat compares VanEck Bionic Engineering UCITS ETF A Acc with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with VanEck Bionic Engineering UCITS ETF A Acc include Charter Court Financial Services Grp (CCFS), Caribbean Investment (CIHL), Permanent TSB Group (IL0A), Polar Capital (POLR), and BMO Global Smaller Companies (BGSC).

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Charter Court Financial Services Grp?

Charter Court Financial Services Grp (LON:CCFS) and VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.

VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Charter Court Financial Services Grp, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Charter Court Financial Services Grp	£221.10M	0.00	N/A	£46.30	N/A
VanEck Bionic Engineering UCITS ETF A Acc	£1.24B	0.15	N/A	-£7.10	N/A

Company	Net Margins	Return on Equity	Return on Assets
Charter Court Financial Services Grp	N/A	N/A	N/A
VanEck Bionic Engineering UCITS ETF A Acc	N/A	N/A	N/A

Charter Court Financial Services Grp pays an annual dividend of GBX 0.09 per share. VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. Charter Court Financial Services Grp pays out 0.2% of its earnings in the form of a dividend. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. VanEck Bionic Engineering UCITS ETF A Acc is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Charter Court Financial Services Grp's average media sentiment score of 0.00 equaled VanEck Bionic Engineering UCITS ETF A Acc'saverage media sentiment score.

Company	Overall Sentiment
Charter Court Financial Services Grp	Neutral
VanEck Bionic Engineering UCITS ETF A Acc	Neutral

Summary

VanEck Bionic Engineering UCITS ETF A Acc beats Charter Court Financial Services Grp on 3 of the 5 factors compared between the two stocks.

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Caribbean Investment?

VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) and Caribbean Investment (LON:CIHL) are both small-cap banks - regional - europe industry companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

Company	Net Margins	Return on Equity	Return on Assets
VanEck Bionic Engineering UCITS ETF A Acc	N/A	N/A	N/A
Caribbean Investment	N/A	N/A	N/A

VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Caribbean Investment, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VanEck Bionic Engineering UCITS ETF A Acc	£1.24B	0.15	N/A	-£7.10	N/A
Caribbean Investment	£29.20M	0.00	N/A	£8.60	N/A

In the previous week, VanEck Bionic Engineering UCITS ETF A Acc's average media sentiment score of 0.00 equaled Caribbean Investment'saverage media sentiment score.

Company	Overall Sentiment
VanEck Bionic Engineering UCITS ETF A Acc	Neutral
Caribbean Investment	Neutral

Summary

Caribbean Investment beats VanEck Bionic Engineering UCITS ETF A Acc on 2 of the 3 factors compared between the two stocks.

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Permanent TSB Group?

Permanent TSB Group (LON:IL0A) and VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) are both small-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends and analyst recommendations.

Permanent TSB Group has higher earnings, but lower revenue than VanEck Bionic Engineering UCITS ETF A Acc. VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Permanent TSB Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Permanent TSB Group	£406M	0.00	£213M	£0.43	N/A
VanEck Bionic Engineering UCITS ETF A Acc	£1.24B	0.15	N/A	-£7.10	N/A

Permanent TSB Group has a net margin of 54.93% compared to VanEck Bionic Engineering UCITS ETF A Acc's net margin of 0.00%. Permanent TSB Group's return on equity of 10.65% beat VanEck Bionic Engineering UCITS ETF A Acc's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Permanent TSB Group	54.93%	10.65%	0.93%
VanEck Bionic Engineering UCITS ETF A Acc	N/A	N/A	N/A

5.4% of Permanent TSB Group shares are owned by institutional investors. 79.1% of Permanent TSB Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Permanent TSB Group's average media sentiment score of 0.00 equaled VanEck Bionic Engineering UCITS ETF A Acc'saverage media sentiment score.

Company	Overall Sentiment
Permanent TSB Group	Neutral
VanEck Bionic Engineering UCITS ETF A Acc	Neutral

Summary

Permanent TSB Group beats VanEck Bionic Engineering UCITS ETF A Acc on 7 of the 8 factors compared between the two stocks.

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Polar Capital?

VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) and Polar Capital (LON:POLR) are both small-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership.

Polar Capital has a net margin of 16.62% compared to VanEck Bionic Engineering UCITS ETF A Acc's net margin of 0.00%. Polar Capital's return on equity of 30.00% beat VanEck Bionic Engineering UCITS ETF A Acc's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VanEck Bionic Engineering UCITS ETF A Acc	N/A	N/A	N/A
Polar Capital	16.62%	30.00%	14.85%

Polar Capital has a consensus price target of GBX 848.33, indicating a potential downside of 2.71%. Given Polar Capital's stronger consensus rating and higher probable upside, analysts plainly believe Polar Capital is more favorable than VanEck Bionic Engineering UCITS ETF A Acc.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VanEck Bionic Engineering UCITS ETF A Acc	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Polar Capital	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

32.0% of Polar Capital shares are owned by institutional investors. 12.9% of Polar Capital shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. Polar Capital pays an annual dividend of GBX 46 per share and has a dividend yield of 5.3%. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend. Polar Capital pays out 115.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Polar Capital has lower revenue, but higher earnings than VanEck Bionic Engineering UCITS ETF A Acc. VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Polar Capital, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VanEck Bionic Engineering UCITS ETF A Acc	£1.24B	0.15	N/A	-£7.10	N/A
Polar Capital	£222.94M	3.70	£41.05M	£40.00	21.80

In the previous week, VanEck Bionic Engineering UCITS ETF A Acc's average media sentiment score of 0.00 equaled Polar Capital'saverage media sentiment score.

Company	Overall Sentiment
VanEck Bionic Engineering UCITS ETF A Acc	Neutral
Polar Capital	Neutral

Summary

Polar Capital beats VanEck Bionic Engineering UCITS ETF A Acc on 12 of the 14 factors compared between the two stocks.

How does VanEck Bionic Engineering UCITS ETF A Acc compare to BMO Global Smaller Companies?

BMO Global Smaller Companies (LON:BGSC) and VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends, media sentiment and valuation.

Company	Net Margins	Return on Equity	Return on Assets
BMO Global Smaller Companies	N/A	N/A	N/A
VanEck Bionic Engineering UCITS ETF A Acc	N/A	N/A	N/A

BMO Global Smaller Companies pays an annual dividend of GBX 0.02 per share. VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. BMO Global Smaller Companies pays out 0.0% of its earnings in the form of a dividend. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. VanEck Bionic Engineering UCITS ETF A Acc is clearly the better dividend stock, given its higher yield and lower payout ratio.

VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than BMO Global Smaller Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BMO Global Smaller Companies	£303.85M	0.00	N/A	£50.70	N/A
VanEck Bionic Engineering UCITS ETF A Acc	£1.24B	0.15	N/A	-£7.10	N/A

In the previous week, BMO Global Smaller Companies' average media sentiment score of 0.00 equaled VanEck Bionic Engineering UCITS ETF A Acc'saverage media sentiment score.

Company	Overall Sentiment
BMO Global Smaller Companies	Neutral
VanEck Bionic Engineering UCITS ETF A Acc	Neutral

Summary

VanEck Bionic Engineering UCITS ETF A Acc beats BMO Global Smaller Companies on 3 of the 5 factors compared between the two stocks.

Get VanEck Bionic Engineering UCITS ETF A Acc News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CYBG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CYBG vs. The Competition

Export

Metric	VanEck Bionic Engineering UCITS ETF A Acc	Banks Industry	Finance Sector	LON Exchange
Market Cap	£190.96M	£190.96M	£13.84B	£2.82B
Dividend Yield	2.25%	2.25%	5.75%	6.18%
P/E Ratio	-1.87	N/A	20.18	367.05
Price / Sales	0.15	15.42	145.74	86,551.12
Price / Cash	0.13	0.13	19.50	27.87
Price / Book	0.04	0.04	2.24	8.00
Net Income	N/A	N/A	£1.14B	£5.89B
7 Day Performance	-0.40%	-0.08%	1.35%	1.04%
1 Month Performance	4.29%	0.86%	2.24%	2.09%
1 Year Performance	N/A	-2.46%	12.63%	76.31%

VanEck Bionic Engineering UCITS ETF A Acc Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CYBG VanEck Bionic Engineering UCITS ETF A Acc	N/A	GBX 13.31 +0.2%	N/A	N/A	£190.96M	£1.24B	N/A	5,762
CCFS Charter Court Financial Services Grp	N/A	N/A	N/A	N/A	£713.62M	£221.10M	6.37	676	Gap Up
CIHL Caribbean Investment	N/A	N/A	N/A	N/A	£35.27M	£29.20M	3.08	N/A	Gap Up High Trading Volume
IL0A Permanent TSB Group	N/A	N/A	N/A	N/A	£12.99M	£406M	5.53	2,236
POLR Polar Capital	1.6143 of 5 stars	GBX 822 flat	GBX 848.33 +3.2%	+97.5%	£776.91M	£222.94M	20.55	135	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:CYBG) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Competitors

CYBG vs. CCFS, CIHL, IL0A, POLR, and BGSC

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Charter Court Financial Services Grp?

Summary

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Caribbean Investment?

Summary

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Permanent TSB Group?

Summary

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Polar Capital?

Summary

How does VanEck Bionic Engineering UCITS ETF A Acc compare to BMO Global Smaller Companies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CYBG vs. The Competition

VanEck Bionic Engineering UCITS ETF A Acc Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Competitors

CYBG vs. CCFS, CIHL, IL0A, POLR, and BGSC

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Charter Court Financial Services Grp?

Which has preferable earnings & valuation, CCFS or CYBG?

Is CCFS or CYBG more profitable?

Is CCFS or CYBG a better dividend stock?

Does the media prefer CCFS or CYBG?

Summary

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Caribbean Investment?

Is CYBG or CIHL more profitable?

Which has higher earnings and valuation, CYBG or CIHL?

Does the media favor CYBG or CIHL?

Summary

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Permanent TSB Group?

Which has better earnings & valuation, IL0A or CYBG?

Is IL0A or CYBG more profitable?

Do insiders & institutionals have more ownership in IL0A or CYBG?

Does the media favor IL0A or CYBG?

Summary

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Polar Capital?

Is CYBG or POLR more profitable?

Do analysts recommend CYBG or POLR?

Do institutionals & insiders believe in CYBG or POLR?

Is CYBG or POLR a better dividend stock?

Which has higher earnings and valuation, CYBG or POLR?

Does the media refer more to CYBG or POLR?

Summary

How does VanEck Bionic Engineering UCITS ETF A Acc compare to BMO Global Smaller Companies?

Is BGSC or CYBG more profitable?

Is BGSC or CYBG a better dividend stock?

Which has better valuation and earnings, BGSC or CYBG?

Does the media favor BGSC or CYBG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CYBG vs. The Competition

VanEck Bionic Engineering UCITS ETF A Acc Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools